When.com Web Search

  1. Ads

    related to: fda approved postpartum depression drug
    • About PPD

      PPD Is More Common Than You

      May Think. Learn More Here.

    • Taking PPD Treatment

      Treatment For PPD Could Help You

      Feel Better. Discover Dosing.

Search results

  1. Results From The WOW.Com Content Network
  2. FDA approves first postpartum depression pill in the US - AOL

    www.aol.com/fda-approves-first-postpartum...

    The US Food and Drug Administration has approved the medication zuranolone for the treatment of major depressive disorder and severe postpartum depression – making it the first FDA-approved oral ...

  3. Zuranolone - Wikipedia

    en.wikipedia.org/wiki/Zuranolone

    Zuranolone was approved by the US Food and Drug Administration (FDA) for the treatment of postpartum depression in August 2023. [6] [13] The FDA granted the application for zuranolone priority review and fast track designations. [6] Approval of Zurzuvae was granted to Sage Therapeutics, Inc. [6]

  4. The first pill to treat postpartum depression has been ... - AOL

    www.aol.com/news/fda-approves-first-postpartum...

    The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 ...

  5. The first oral pill to treat postpartum depression is ... - AOL

    www.aol.com/lifestyle/fda-approved-pill-treat...

    In August the Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication to treat postpartum depression. The approval is a big step for women with the condition, which ...

  6. The first pill for postpartum depression is finally getting ...

    www.aol.com/first-pill-postpartum-depression...

    The first-ever pill for postpartum depression, zuranolone, was approved last year. ... The Food and Drug Administration approved the drug in August, but it took months for supply to become ...

  7. Allopregnanolone - Wikipedia

    en.wikipedia.org/wiki/Allopregnanolone

    The FDA approved allopregnanolone based on evidence from three clinical trials, conducted in the United States, (Trial 1/NCT02942004, Trial 3/NCT02614541, Trial 2/ NCT02942017) of 247 women with moderate or severe postpartum depression. [58] The FDA granted the application for brexanolone priority review and breakthrough therapy designations ...

  1. Ads

    related to: fda approved postpartum depression drug